In the QUESTIONS AND ANSWERS section of the Feb 7 issue ofThe Journal(237:579, 1977), an incorrect drug was mentioned in the answer to a question concerning recurrent herpes simplex and concomitant headaches for 12 years. On page 579, column 2, lines 5 and 6, the drug used for intralesional injections should be triamcinolone acetonide (Kenalog) enanthate or triamcinolone hexacetonide (Aristospan) instead of the topical cream triamcinolone acetonide (Aristocort A).